Baricitinib had previously attracted some scrutiny from experts, who were unsure when it would most help their patients.
Covid Patient Study Shows Some Benefit From an Arthritis Drug
Baricitinib had previously attracted some scrutiny from experts, who were unsure when it would most help their patients.